HLA-C and glioblastoma: In various tumors, including GBM, LGG, and OV, GSDMD demonstrated a significant positive correlation with a majority of immune modulation genes, such as chemokine receptors, MHC, immune inhibitors, and immune stimulators (Figure 3E).